Gil Melchior
Investor Relations
Replay available
Trupanion, Inc. (NASDAQ: TRUP) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.

Investor Relations
Analyst, William Black & Co.
Analyst, Bank of America Securities
Analyst, Raymond James
Chief Executive Officer and President
Chief Financial Officer
Hello, and welcome to the Trupanion Second Quarter 2026 Earnings Conference Call. All participants will be on listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your telephone keypad. To try your question, please press star, then two. Please note, this event is being recorded. Now I turn the conference over to Gil Melchior. Please go ahead. Good afternoon, and welcome to DuPennyon's second quarter 2026 Financial Results Conference Call. Participating on today's call are Margie Tooth, Chief Executive Officer and President, and Fawwad Qureshi, Chief Financial Officer. Before we begin, please be advised that remarks today will contain forward-looking statements. All statements are then statements of historical facts or forward-looking statements. These include, but are not limited to, statements regarding our future operations, key operating metrics, opportunities and financial performance, pricing, and veterinary industry inflation. These statements involve a high degree of known and unknown risks and uncertainties that could cause actual results to differ materially from those discussed. A detailed discussion of these and other risks and uncertainties are included in today's earnings release as well as the company's most recent reports, including forms 10-K, 10-Q, and 8-K filed with the Securities and Exchange Commission. Today's presentation contains references to non-GAAP financial measures that management uses to evaluate the company's performance, including without limitation, cost of paying veterinary invoices, variable expenses, fixed expe...